Dell Electronic Lab Notebook Solution Unleashes Information For Pharmaceutical And Biotech Researchers With pharmaceutical and biotech companies spending billions of dollars to bring new
drugs to market, many are turning to Dell to help improve their research efficiency and collaboration while helping to lower the cost of discovering new therapeutics through Dell's electronic lab notebook (ELN) solution bundle.
Source: www.medicalnewstoday.comMalarial Parasite More Serious Than Previously Thought Plasmodium vivax can cause malaria and substantialmorbidity and mortality, especially in young children, according to twostudies released on June 16, 2008 in the open access journal PLoS
Medicine. Seldom fatal and less virulent than some other malarial strains such asP. falciparum, P. vivaxwas generally considered benign before this set of studies.
Source: www.medicalnewstoday.comNovel PEGylated Anti-TNF Drug Cimzia Is First To Demonstrate X-ray Proof Of Significant Early Joint Protection In Rheumatoid Arthritis The first PEGylated, Fc-free, anti-tumour necrosis factor (TNF) alpha agent Cimzia (certolizumab pegol), in development for rheumatoid arthritis (RA) as an add-on therapy to methotrexate (MTX), has demonstrated X-ray evidence of ability to protect joints from structural damage at an unprecedented early stage (16 weeks).
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 2:02 AM
